ATLANTA, Jan. 5, 2011 /PRNewswire/ -- Elekta's MOSAIQ® Oncology Information System (OIS)—the market's leading open-system, vendor-neutral OIS—has earned the No. 1 ranking in the oncology software category from KLAS, an independent research firm. According to KLAS, a Category Leader designation identifies top-rated vendor products in the Top 20 Best in KLAS Awards report for each market segment.
The 2010 Top 20 Best in KLAS Awards: Software and Professional Services report provides a summary of the KLAS performance ratings gathered over the past 12 months for healthcare IT software and service vendors in 113 market segments. Each segment includes a listing of vendor products ranked according to their KLAS performance scores, which have been compiled from the feedback from 17,667 healthcare providers.
"The unique ability to streamline clinical operations and enable clinics to integrate vendor-neutral hardware and software has always been a valued cornerstone of the MOSAIQ OIS," says Todd Powell, Executive Vice President, Elekta Software. "We're honored to have MOSAIQ recognized as being such a valuable contributor to patient care."
In September, Elekta also received the No. 1 ranking in the KLAS 2010 report, The Oncology IT Balancing Act: Integration vs. Functionality. In this report, Elekta received top scores in six categories, including:
MOSAIQ OIS streamlines radiation oncology and medical oncology workflow from the first encounter, through diagnosis and staging, planning, treatment and long-term follow-up. At the heart of MOSAIQ is the image-enabled electronic medical record (EMR) by which healthcare professionals communicate information about their patients throughout the continuum of cancer care.
Leveraging more than 20 years of leadership and expertise of IMPAC Medical Systems, MOSAIQ continues to set the standard for vendor-independent linac connectivity and remains a fixture in many of the world's leading cancer care facilities. More than 1,400 global customers count on Elekta software to help them provide the safest and most efficient treatments in the fight against cancer. From its multiple redundant safety features to industry-leading practice management capabilities, MOSAIQ is the tool of choice to manage cutting-edge treatment centers.
Learn more about MOSAIQ at www.elekta.com/MOSAIQ.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
KLAS is an independent research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors and vendors. Working together with executives from more than 4,500 hospitals and over 2,500 clinics, KLAS delivers timely reports, trends and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures the performance of software, professional services and medical equipment vendors. For more information, go to www.KLASresearch.com, email marketing@KLASresearch.com or call 1-800-920-4109 to speak with a KLAS representative. Copyright© 2010 KLAS Enterprises, LLC. All rights reserved.
Copyright©2010 PR Newswire.
All rights reserved